Tag: Lifitegrast

In 2023, eye health company Bausch + Lomb acquired Xiidra from Novartis in a deal worth up to $2.5 billion. For patients wondering, “Is Xiidra being discontinued?”, this change in ownership confirms the medication's continued availability and future in the dry eye treatment market.

Chronic dry eye disease affects millions of adults, causing discomfort and irritation. The answer to the question, **'Can you buy XIIDRA over-the-counter?'** is no, as this targeted anti-inflammatory eye drop is only available with a doctor's prescription.

While most clinical studies for Xiidra did not identify dizziness as a common side effect, official patient information acknowledges that it may be a possible side effect in certain individuals. User reports have also linked the medication to dizziness, and severe dizziness can be a rare but serious symptom of an allergic reaction. It is important to understand the context and severity of this potential adverse event.

Over 16 million Americans are affected by dry eye disease, and while Xiidra is a common prescription, it doesn't work for everyone. For those seeking more effective options, the question of **what works better than Xiidra?** is an important one, with several promising alternatives available, from other prescription drops to innovative procedures.

Over 30 million Americans are estimated to suffer from chronic dry eye syndrome, a condition that can cause significant discomfort and impact vision. While over-the-counter artificial tears may provide temporary relief for mild cases, those with persistent or severe symptoms often require a doctor to determine what prescription is used for dry eyes to address the underlying causes.

According to clinical studies, patients using Xiidra showed statistically significant improvements in both the signs and symptoms of dry eye. So, does Xiidra produce more tears? The answer is yes, but not by simply adding them; rather, it works by addressing the root cause of inflammation that impairs the eye's natural tear-producing ability.

Sjögren's syndrome is a chronic autoimmune disease affecting the body's moisture-producing glands. While not officially FDA-approved for Sjögren's itself, the question of 'Does Xiidra work for Sjögren's?' is critical for patients experiencing severe dry eye, a primary symptom of the condition.

With an average cash price often exceeding $800 for a 30-day supply, many patients naturally wonder, "Why are Xiidra eye drops so expensive?". The high cost is largely a product of its status as a brand-name pharmaceutical with patent protection, high research and development costs, and a unique mechanism of action.

As of September 2025, there is no therapeutically equivalent generic for Xiidra ophthalmic solution available in the United States. This means that the brand-name version, containing the active ingredient lifitegrast, is the only product currently on the market for this specific formulation.

According to the American Journal of Ophthalmology, the prevalence of dry eye disease was reported as 10.2% among adults in the United States. When over-the-counter options fail, a professional diagnosis is crucial to determine what is the best prescription for severe dry eyes based on the underlying cause.